C₂N Diagnostics announced the planned launch of its new diagnostic blood test, PrecivityAD2, which uses mass spectrometry and a statistical algorithm to detect the two key drivers behind Alzheimer’s disease — tau and amyloid beta proteins. Read More

Women with breast or ovarian cancer had fewer hot flashes, less psychiatric distress and better quality of life after using XRHealth’s virtual reality (VR)-artificial intelligence (AI)- based technology, researchers reported in the journal Healthcare. Read More

A research team in Massachusetts has developed a “deep learning” tool that can search cardiac X-rays (CXR) to find patterns associated with atherosclerotic cardiovascular disease (CVD), accurately predicting major cardiac events over the span of 10 years, according to study results presented at the Radiological Society of North America meeting in Chicago, Nov. 27-Dec. 1. Read More

John Hopkins Kimmel Cancer Center in Baltimore, Md., used artificial intelligence (AI) blood test technology to detect more than 80 percent of liver cancers in current liver cancer and at-risk patients. Read More

SpaceX’s upcoming resupply mission to the International Space Station (ISS) National Laboratory will test the viability of a new remote-controlled drug delivery implant to provide extended, adjustable medication from afar. Read More

Cybersecurity relates closely to both design controls and risk management in the medical device arena. So, any efforts to address cybersecurity must be incorporated into existing design and development planning, as well as overall risk management practices. That means that companies cannot simply stick an authentication algorithm or other Band-Aid on their connected device and be in compliance with regulations. Read More